Why It's Time to Digitize Clinical Trial Sites — And What's Holding Us Back

Clinical trial sites continue to rely on paper, email, and disconnected systems — even as study complexity and oversight demands increase. While the benefits of digitization are widely understood, progress remains uneven. Operational inertia, inconsistent technology adoption, and concerns around change management often slow momentum. The result is avoidable inefficiencies that strain site staff, limit visibility for sponsors, and introduce unnecessary risk.

Meaningful digitization focuses on simplifying everyday site workflows rather than adding new layers of technology. Centralized access to study documents, standardized processes, and systems designed around how sites actually work can reduce administrative burden while improving compliance and collaboration. Addressing cultural resistance, misaligned incentives, and fragmented infrastructure is just as critical as selecting the right tools.

Understanding what’s holding sites back — and how to move forward — can help clinical teams build more resilient, scalable trial operations. Explore the full piece to see practical paths toward progress.